At GeneVide, we utilize a novel molecular enzyme iterative optimization platform based on enzyme characterization methods as our innovation engine. Through the development of Enzyme-mediated one-step sample processing (EmOSP) and Enzymes-mediated Duplex Exponential Amplification (EmDEA), we have successfully built a molecular diagnostic system with independent intellectual property rights that enables us to develop fast, accurate, simple, portable and affordable real-time tests to serve the communities in pandemic seasons.